Journals / Retina-Vitreus / 2010 / Cilt: 18 - Sayı: 1

Kronik Santral Seröz Korioretinopati Tedavisinde Fotodinamik Tedavi Sonuçları

The Results of Photodynamic Therapy in the Treatment of Central Serous Chorioretinopathy

Pages
23–28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Photodynamic therapy was considered as a safe and effective method in the treatment of chronic CSC

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the efficacy and results of photodynamic therapy (PDT) in the treatment of chronic central serous chorioretinopathy (CSC) which persists longer than six months.
📊
Key Findings & Data:Material and Methods: Fifteen eyes of 14 patients with subfoveal fluid which persisted longer than 6 months were included in the study.
💡
Conclusion & Impact:Photodynamic therapy was considered as a safe and effective method in the treatment of chronic CSC
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the efficacy and results of photodynamic therapy (PDT) in the treatment of chronic central serous chorioretinopathy (CSC) which persists longer than six months. Material and Methods: Fifteen eyes of 14 patients with subfoveal fluid which persisted longer than 6 months were included in the study. Visual acuities and contrast sensitivities of the patients were measured before and after the treatment. Infrared fundus photographies, fundus fluorescein and indocyanine green angiographies were performed. Central macular thickness and macular volume values were obtained with optical coherence tomography. Results: The mean age of the patients was 49±6.3 years. Mean follow-up period was 15.3±13.6 months. Visual acuity (VA) increased more than 2 lines in 12 (80%) eyes after PDT. Visual acuity decreased 1 line in 1 (6.6%) eye; remained unchanged in 1 (6.6%) eye and increased 1 line in 1 (6.6%) eye. The mean contrast sensitivity did not change significantly after PDT. A statistically significant decrease in the mean central macular thickness and total macular volume was observed after the treatment compared to pretreatment (p=0.001). Eleven (73.3%) eyes had complete resolution and 4 (26.7%) eyes had partial resolution of subretinal fluid in OCT. No complication was observed due to PDT. Conclusion: Photodynamic therapy reduced subretinal fluid and improved visual acuity in patients with chronic CSC of longer than six moths duration. Photodynamic therapy was considered as a safe and effective method in the treatment of chronic CSC

Özet

Amaç: Altı aydan uzun süren kronik santral seröz korioretinopatinin (SSKR) tedavisinde fotodinamik tedavinin (FDT)etkinliği ve sonuçlarını değerlendirmek.Gereç ve Yöntem: Çalışmaya 6 aydan uzun süredir subfoveal sıvısı bulunan 14 olgunun 15 gözü dahil edildi. Tedavi öncesi ve sonrasında olguların görme keskinliği ve kontrast duyarlılık değerleri ölçüldü. İnfrared fundus fotoğrafisi, fundus floresein ve indosyanin yeşili anjiografileri yapıldı. Optik koherens tomografi (OKT) ile santral makula kalınlığı ve makula hacmi elde edildi. Bulgular: Olguların ortalama yaşı 49±6.3 idi. Ortalama takip süresi 15.3±13.6 aydı. Fotodinamik tedavi sonrası 12 (%80) olgunun görme keskinliğinde 2 sıra ve üzerinde artış görüldü. Bir (%6.6) olguda görme keskinliği değişmezken, 1 (%6.6) olguda 1 sıra azaldı. Ortalama kontrast duyarlılıkta FDT sonrasında anlamlı bir değişiklik olmadı. Ortalama santral makula kalınlığı ve total makula hacminde FDT öncesi ve sonrası değerler karşılaştırıldığında istatistiksel olarak anlamlı bir azalma gözlendi (p=0.001). Optik koherens tomografide subretinal sıvının 11 (%73.3) gözde tam, 4 (%26.7) gözde kısmen gerilediği görüldü. Hiç bir gözde FDT'ye bağlı bir komplikasyon gelişmedi. Sonuç: Fotodinamik tedavi 6 aydan uzun süren kronik SSKR'li olgularda subretinal sıvının gerilemesi ve görme keskinliğinin attırılmasında güvenli ve etkili bir yöntem olarak değerlendirilmiştir

🔖

Cite This Article

ALKIN, Z., KAPRAN, Z., ALTAN, T., UZUN, E., ACAR, N., ÜNVER, Y. B. (2010). Kronik Santral Seröz Korioretinopati Tedavisinde Fotodinamik Tedavi Sonuçları. Retina-Vitreus, Cilt: 18 - Sayı: 1, 23–28. https://ajindex.com/articles/305137

References (13)

  1. Klais CM, Ober MD, Ciardella AP, et al.: Central serous chori- oretinopathy. In Ryan SJ: Retina The CV Mosby Co. St. Louis. 2006;2:1135-1161. Gass JDM.: Stereoscopic atlas of macular diseases: diagnosis and treatment. St. Louis: Mosby. 1997:52-70.
  2. Hussain D, Gass JD.: Idiopathic central serous choriretinopathy. Indian J Ophthalmol. 1998;46:131-137.
  3. Gilbert CM, Owens SL, Smith PD, et al.: Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol. 1984; 68:815-820.
  4. Yannuzzi LA, Shakin JL, Fisher YL, et al.: Peripheral detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology. 1984;91:1554- 1572. Jalkh AE, Jabbour N, Avila MP, et al.: Retinal pigment epithelium decompensation. I. Clinical features and natural course. Oph- thalmology. 1984;91:1544-1548.
  5. Levine R, Brucker A, Robinson F.: Long-term follow-up of idiopat- hic central serous chorioretinopathy by fluorescein angiography. Ophthalmology. 1989;96:854-859.
  6. Loo RH, Scott IU, Flynn HW Jr, et al.: Factors associated with re- duced visual acuity during long-term follow-up patients with idio- pathic central serous chorioretinopathy. Retina. 2002;22:19-24.
  7. Piccolino FC, Borgia L, Zinicola E, et al.: Indocyanine gren angi- ographic findings in central serous chorioretinopathy. Eye. 1995; 9:324-332.
  8. Prunte C, Flammer J.: Choroidal capillary and venous congesti- on in central serous chorioretinopathy. Am J Ophthalmol. 1996; 121:26-34.
  9. Pikkel J, Beiran I, Ophir A, et al.: Acetazolamide for central sero- us retinopathy. Ophthalmology. 2002;109:1723-1725. Browning DJ.: Nadolol in the treatment of central serous retino- pathy. Am J Ophthalmol. 1993;116:770-771.
  10. Khosla PK, Rana SS, Tewari HK, et al.: Evaluation of visual functi- on following argon laser photocoagulation in central serous reti- nopathy. Ophthalmic Surg Lasers. 1997;28:693-697.
  11. Burumcek E, Mudun A, Karacorlu S, et al.: Laser photocoagula- tion for persistent central serous retinopathy: results of long-term follow-up. Ophthalmology. 1997;104:616-622.
  12. Yannuzzi LA, Slakter JS, Kaufman SR, et al.: Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol. 1992;2:103-114.
  13. Yannuzzi LA, Slakter JS, Gross NE, et al.: Indocyanine gre- en angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy. A pilot Study. Retina. 2003;23:288-298. Treatment of Age-Related Macular Degeneration With Photody- namic Therapy (TAP) Study Grou